
Nabla generates clinical notes ambiently from the consultation, and is one of very few scribes with a free tier — reportedly 30 consultations a month. That free tier comes with a caveat serious enough to lead with: it reportedly does not include a signed Business Associate Agreement, which means it is not suitable for identifiable patient health information. As an evaluation sandbox it's useful. As a way to document real patients for free, it isn't one. Nabla also appears to have moved to demo-and-contract sales during 2026.
| Platforms | Web, iOS, Android |
| Free tier | Reportedly 30 consultations/month — reportedly no BAA |
| Starter | Reported around $119/month per clinician |
| Pro | Reported around $239/month per clinician |
| Sales model | Moved to demo/contract sales during 2026 |
| Compliance | HIPAA on paid plans; confirm BAA coverage for your plan |
| Processing | Cloud |
A free tier reportedly covering 30 consultations a month, without a BAA. Starter is reported at around $119 per clinician per month and Pro at around $239. Nabla moved to demo and contract sales during 2026, so current pricing may be quote-based. Confirm directly, and confirm BAA coverage on whichever plan you choose.
Clinicians who want to evaluate ambient scribing at no cost before paying — using simulated or de-identified encounters, not real patients. If you decide it works, price Starter against Freed at $79 for unlimited notes. For health-system deployment, Abridge has far stronger independent validation.
Last verified: 10 August 2026. Pricing and BAA terms are reported by third parties and appear to be changing; verify everything directly with Nabla before clinical use.